Federico Paoletti ^UDM

Federico Paoletti, as CEO & Co-Founder of Exogene Ltd. in the UK, is involved in cutting-edge biotechnology research, learning and adapting every day in a dynamic field. His company is focused on leveraging computational approaches to accelerate the discovery and engineering of T-cell receptor-based therapeutics. In addition to his role at Exogene, Paoletti is a cohort member at KQ Labs, contributing to their efforts to empower data-driven health startups.